Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00152022
Status:
COMPLETED
Last Update Posted:
2021-07-13
First Post:
2005-09-07
Brief Title:
Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD
Sponsor:
Shire
Organization:
Takeda
Study Overview
Official Title:
A Phase III Randomized Double-blind Multi-center Placebo-controlled Parallel-Group Safety and Efficacy Study of SPD465 in Adults With Attention-Deficit Hyperactivity Disorder ADHD
Status:
COMPLETED
Status Verified Date:
2021-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the safety and effectiveness of SPD465 compared to placebo a capsule with no medication in it in the treatment of ADHD The study will also look at how SPD465 affects the participants sleep and how they perceive their quality of life
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None